Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment

Completed

• Conditions: Pancreatic Cancer

• Registration Number: NCT00294840
• Lead Sponsor: Rambam Health Care Campus

Brief Summary

To assess a quantitative kinetic model of FDG uptake measurement using PET in patients with aggressive Non-Hodgkin's lymphoma and cancer of the pancreas, malignancies with known variability in disease aggressiveness and prognosis, for optimized tailoring of the therapeutic strategy in the individual patient.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-02-20
• Study First Submitted QC: 2006-02-20
• Study First Posted: 2006-02-22
• Study Start: 2006-08
• Status Verified: 2008-05
• Primary Completion: 2009-09
• Study Completion: 2010-04
• Last Update Submitted: 2010-07-28
• Last Update Posted: 2010-07-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

• age>18
• newly diagnosed untreated aggressive NHL
• newly diagnosed untreated cancer of pancreas

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The impact of the imaging modality on patient management	5 years

Secondary Outcome Measures

Name	Time	Method
patient management	10 years

Trial Locations

Locations (1)

Rambam Medical Center; 🇮🇱 Haifa, Israel